Overseas New Orders Maintained Rapid Growth
发布时间:2026-11-01 来源:华泰证券
CNCEC released its 3Q26 results: 9M26 revenue came in at RMB137,659mn (+1.00% YoY), with attributable NP of RMB4,324mn (+2.17% YoY) and recurring NP of RMB4,247mn (+5.81% YoY). In 3Q26, revenue was RMB45,950mn (+0.82% YoY, +0.76% QoQ), and attributable NP was RMB1,179mn (+4.27% YoY, -25.31% QoQ), broadly in line with our estimate of RMB1,131mn. In 9M26, the company achieved steady revenue and profit growth, while overseas new contracts maintained rapid growth. Against rising global energy security demand, we expect growing investments in domestic coal-to-chemical capacity expansion, and combined with overseas business expansion, the company is well-positioned to benefit. Maintain BUY.
GPM YoY improved; expense ratio up on increased R&D spending
9M26 overall gross margin was 10.25% (+0.53pp YoY), with 3Q26 gross margin at 9.84% (+0.71pp YoY, -0.80pp QoQ). The 9M26 period expense ratio was 5.76% (+0.13pp YoY), with sales/administrative/R&D/financial expense ratios at 0.27/1.85/3.47/0.17% (+0.02/-0.09/+0.15/+0.05pp YoY). 9M26 impairment expenses totaled RMB200mn, vs a reversal of RMB169mn in the year-ago period. As a result, 9M26 attributable NPM/recurring NPM was 3.14/3.09% (+0.04/+0.14pp YoY); 3Q26 attributable NPM/recurring NPM was 2.57/2.48% (+0.08/+0.27pp YoY).
9M26 operating cash flow YoY notably improved
9M26 net operating cash flow was RMB878mn, with inflows expanding by RMB6,453mn YoY. The core business cash receipts-to-revenue ratio/cash payment-to-cost ratio was 98.5/94.9% (-4.50/-6.22pp YoY). In 3Q26 alone, net operating cash flow was RMB798mn, with inflows narrowing by RMB3,659mn YoY. On one hand, the core business cash receipts-to-revenue ratio and cash payment-to-cost ratio were 100.2/90.7% (-9.3/-7.1pp YoY), with the receipts ratio declining notably. On the other hand, cash inflows from financial operations fell by RMB3,212mn YoY, while cash outflows from financial operations declined by RMB919mn YoY, resulting in a net decrease of RMB2,293mn. At end-3Q26, accounts receivable/contract assets were RMB41,451/52,792mn, up 2.83/8.18% from the beginning of the year. The liability-to-asset ratio was 69.30%, down 0.56pp from the beginning of the year.
Overseas orders sustained high growth
9M26 new contracts totaled RMB285,366mn (+0.28% YoY). Newly signed domestic/overseas contracts were RMB187,662/97,704mn (-18.73/+82.11% YoY), with the overseas share rising by 15.38pp YoY to 34.24%. In 3Q26, new contracts were RMB75,876mn (-3.30% YoY), including overseas contracts of RMB24,769mn (+103.56% YoY), with overseas increments partially offsetting the domestic decline. By segment, 9M26 new engineering contracts were RMB274,677mn, of which chemical engineering accounted for RMB247,662mn, representing 86.79% of total new contracts. New industrial/modern services contracts were RMB10,158/531mn. In September 2026, CNCEC signed projects including a 300MW photovoltaic EPC project in Ghana and the FGL revamp and expansion EPCC project in Algeria, with corresponding contract values of c. RMB2,580/1,612mn, as overseas market expansion continued. We believe overseas order growth is likely to support subsequent revenue recognition.
Earnings forecasts and valuation
We maintain our 2026/2027/2028 attributable NP forecasts at RMB6,822/7,205/ 7,514mn. We value the stock at 10x 2026E PE, in line with its peers' average on Wind consensus. We maintain our target price of RMB11.17 and BUY rating.
Risks: persistent GPM contraction, sharp fluctuations in overseas operations, industrial chemical investments falling short of our forecast.